MACROGENICS INC

MGNX · NASDAQ

Updated at 2026-10-14 09:06:44

$3.42-8.06%
Today's High
$3.73
Today’s Low
$3.38
MACROGENICS INC (MGNX) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$3.72
Previous Close
$3.72
Volume
284.71K
Market Cap
$236.96M
P/E Ratio
--
EPS
$-0.23

Previous Day Range

$3.65$3.76

52-Week Range

$1.29$5.08

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
9704 MEDICAL CENTER DRIVE, ROCKVILLE, MD, UNITED STATES, 20850
Country
US
Listing Date
2013-10-10
Fiscal Year End
December
Shares Outstanding
63.56M
CIK
0001125345

MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States. The company is headquartered in Rockville, Maryland.

Financial Metrics

Revenue

2026-06-30

$32.83M

2026-03-31

$20.77M

2025-12-31

$41.22M

2025-09-30

$72.83M

Operating Expenses

2026-06-30

$46.68M

2026-03-31

$42.99M

2025-12-31

$41.5M

2025-09-30

$40.82M

Net Income

2026-06-30

$19.51M

2026-03-31

-$36.77M

2025-12-31

-$14.15M

2025-09-30

$16.82M

Net Profit Margin

2026-06-30

59.43%

2026-03-31

-177.01%

2025-12-31

-34.33%

2025-09-30

23.09%

Earnings Per Share

2026-06-30

$-0.27

2026-03-31

$-0.58

2025-12-31

$-0.22

2025-09-30

$0.27

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$64.53M

2026-03-31

-$30.19M

2025-12-31

-$8.95M

2025-09-30

$21.95M

Effective Tax Rate

2026-06-30

128.02%

2026-03-31

--

2025-12-31

5.2%

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.